
20th World Congress of Basic and Clinical Pharmacology 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 20th World Congress of Basic and Clinical Pharmacology 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
World Congress of Basic and Clinical Pharmacology 2026
Event type: Pharmacology, Drug Discovery, Clinical Research, Translational Medicine, Life Sciences, Medical Research, Academic & Industry Conference
Best use case: High-value buyer research for pharma, biotech, CROs, universities, hospitals, research labs, clinical trial organizations, and scientific solution providers
Estimated attendance: Typically a global scientific congress of this kind can attract several thousand delegates, with a strong mix of researchers, clinicians, educators, students, and industry representatives. For list-building purposes, the real buyer value sits in senior scientific and commercial stakeholders rather than general attendees.
Event Overview
The World Congress of Basic and Clinical Pharmacology 2026 is a high-level scientific event focused on pharmacology, drug development, clinical translation, medical innovation, and research collaboration. This is not a conventional trade show dominated by retail buyers or casual visitors. It is a specialized knowledge-driven congress where the most valuable contacts are found among pharmaceutical leaders, biotech decision-makers, clinical researchers, academic faculty, healthcare innovators, laboratory heads, and scientific suppliers.
From a buyer-list perspective, this event is especially valuable for companies selling research tools, laboratory technologies, clinical trial services, data platforms, medical devices, diagnostics, regulatory services, education solutions, and pharma-related consulting.
1️⃣ Who attends: Buyers / Attendees
The attendee base is composed of both scientific and commercial stakeholders. While many participants attend for education, networking, and research exchange, there are clear buyer segments with budget authority or strong influence over purchasing decisions.
Main attendee groups:
- Clinical pharmacologists and basic pharmacology researchers
- Pharmaceutical R&D leaders
- Drug discovery scientists
- Translational medicine specialists
- Principal investigators, professors, and department heads
- Hospital research leaders and clinical investigators
- Biotech founders and scientific executives
- Regulatory affairs professionals
- Clinical trial managers and operations leaders
- Laboratory directors and technical specialists
- Medical affairs and medical science liaison teams
- Scientific vendors, sponsors, and solution providers
- Postdoctoral researchers, fellows, and graduate students
For buyer list purposes, the strongest contacts are not necessarily the largest student audience. The best prospects are the people who influence adoption of platforms, instruments, reagents, software, services, training programs, and partnerships.
2️⃣ Where the show is happening + attendee geographic origin
The event is a global pharmacology congress, so the attendee origin is typically international, with delegates coming from multiple regions such as North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa. The actual venue location should be confirmed from the official event website before final targeting, because the geographic mix changes depending on where the congress is hosted.
Geographic targeting guidance:
- If hosted in Europe: expect strong regional participation from EMEA plus global academic attendance
- If hosted in North America: expect North American pharma, biotech, university, and clinical research participation, with international delegates as well
- If hosted in Asia-Pacific: expect strong local/regional research participation and growing multinational presence
Because this is a scientific congress rather than a regional consumer event, the attendee base is usually global by design. That makes it attractive for companies looking for international research, clinical, and pharma buyers.
3️⃣ Audience reach
Reach type: Global
This event has global reach because pharmacology is a worldwide discipline and congress delegates are usually drawn from international academic institutions, pharmaceutical companies, clinical networks, and research organizations. Even if the physical event is hosted in one country, the audience can still be multinational and highly specialized.
For commercial outreach, the global reach is important because it increases the likelihood of finding senior scientific buyers with cross-border influence, especially in pharma, biotech, CRO, diagnostics, and research equipment segments.
4️⃣ Sample buyer company names + websites
Below are sample buyer companies that are strong fits for this event. These are not random brands; they are organizations that are likely to attend, sponsor, exhibit, or send decision-makers because their business touches pharmacology, clinical research, drug development, laboratory science, or healthcare innovation.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Pfizer | pfizer.com | Director, Clinical Development / R&D Program Manager | Major pharma company with strong interest in drug research, clinical trials, and scientific partnerships. |
| 2 | Roche | roche.com | Global Medical Affairs Lead / Translational Medicine Director | Strong buyer for pharmacology, diagnostics, clinical innovation, and research collaboration. |
| 3 | Novartis | novartis.com | Head of Clinical Research / Scientific Operations Lead | Relevant across drug discovery, clinical research, and therapeutic development. |
| 4 | AstraZeneca | astrazeneca.com | Director, Translational Science / Clinical Strategy Manager | Active in global research, development pipelines, and scientific conferences. |
| 5 | Merck & Co. | merck.com | Associate Director, Clinical Pharmacology / R&D Partnerships Lead | Excellent fit for pharmacology, clinical studies, and innovation sourcing. |
| 6 | Johnson & Johnson | jnj.com | Medical Science Liaison Manager / Clinical Research Director | Strong healthcare and life sciences presence with broad research and clinical interests. |
| 7 | Sanofi | sanofi.com | Director, Global Clinical Operations / Scientific Affairs Lead | Large pharma buyer for trial operations, scientific education, and research partnerships. |
| 8 | GSK | gsk.com | Head of Clinical Science / Research Partnerships Manager | Strong conference fit due to its focus on therapeutics, vaccines, and clinical science. |
| 9 | Bayer | bayer.com | Pharmacology Research Lead / Innovation Manager | Good buyer for drug development, life sciences, and healthcare-related solutions. |
| 10 | Thermo Fisher Scientific | thermofisher.com | Life Sciences Marketing Director / Scientific Partnerships Manager | Major supplier to pharma and research labs; strong conference attendance potential. |
| 11 | Labcorp | labcorp.com | Director, Clinical Trial Services / Business Development Manager | Highly relevant for clinical research, trial support, and laboratory services. |
| 12 | IQVIA | iqvia.com | Vice President, Clinical Operations / Pharma Solutions Lead | Excellent fit for data-driven clinical research and pharmaceutical services. |
| 13 | Charles River Laboratories | criver.com | Director, Preclinical Services / Scientific Sales Manager | Directly aligned with drug development, preclinical research, and pharmacology studies. |
| 14 | Syneos Health | syneoshealth.com | Clinical Solutions Director / Account Executive, Pharma Services | Strong buyer for outsourced pharma services, clinical operations, and commercialization support. |
| 15 | Medpace | medpace.com | Director, Clinical Project Management / Business Development Director | Highly relevant CRO with direct interest in clinical research and trial partnerships. |
| 16 | Wuxi AppTec | wuxiapptec.com | Head of Business Development / Drug Discovery Services Director | Strong fit for outsourcing, preclinical development, and research services. |
| 17 | Amgen | amgen.com | Clinical Development Director / Research Program Lead | Biopharma leader with strong relevance in clinical science and drug innovation. |
| 18 | Takeda | takeda.com | Global Scientific Affairs Manager / Clinical Research Lead | Large research-driven pharma buyer with broad therapeutic focus. |
5️⃣ Job profiles, industries & event type
This congress attracts a very specific buyer ecosystem. The most valuable contacts are the people who control research agendas, clinical trial planning, product evaluation, scientific collaborations, and budget allocation for research tools or services.
Best job profiles to target:
- Director of Clinical Research
- Head of Pharmacology
- Clinical Development Director
- Translational Medicine Director
- R&D Program Manager
- Scientific Affairs Manager
- Medical Science Liaison
- Regulatory Affairs Director
- Biostatistics Lead
- Clinical Trial Manager
- Laboratory Director
- Preclinical Research Manager
- Drug Discovery Scientist
- Business Development Director, Life Sciences
- Research Partnerships Manager
- Professor / Department Chair / Principal Investigator
Best industries to target from your industry list:
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Hospital & Health Care
- Research
- Higher Education
- Education Management
- Health, Wellness & Fitness
- Information Services
- Management Consulting
- Market Research
- Professional Training & Coaching
- Computer Software
- Information Technology & Services
- Laboratory, diagnostics, and scientific services companies, using keyword-based matching where industry tags may be broad
The event type is best described as a scientific and academic congress with strong industry participation. That means the audience is more sophisticated than a normal expo crowd and usually responds better to technical, research-based, evidence-driven messaging.
6️⃣ Estimated attendance / expected footfall
Since this is a world congress, attendance is usually measured in thousands rather than tens of thousands. The exact figure should be confirmed from the organizer’s website, but these events often attract:
- Scientific delegates from multiple countries
- Academic researchers and postgraduate attendees
- Industry sponsors and exhibitors
- Clinicians and healthcare professionals
- Students and early-career researchers
For list-selling purposes, the total footfall matters less than the quality of the contact mix. Even a smaller congress can be a strong buyer source if it includes senior pharma, biotech, CRO, and academic decision-makers.
7️⃣ Key focus areas & buyer engagement
Core focus areas:
- Basic pharmacology
- Clinical pharmacology
- Drug discovery and development
- Translational medicine
- Precision medicine
- Clinical trials and operations
- Pharmacokinetics and pharmacodynamics
- Safety, efficacy, and therapeutic innovation
- Regulatory science
- Education and research collaboration
Buyer engagement is strongest when the outreach is framed around scientific needs and commercial outcomes. Examples include:
- Research tools and laboratory platforms
- Clinical trial recruitment and operations services
- Data analytics and evidence-generation software
- Pharma consulting and regulatory support
- Scientific education and training solutions
- Diagnostic and biomarker-related technologies
- Laboratory consumables, instrumentation, and testing services
A strong buyer message for this event would be: “We can help you reach pharmacology leaders, clinical researchers, biotech innovators, university faculty, and pharmaceutical decision-makers attending the 2026 World Congress.”
8️⃣ Client-product fit note
Please share your client website before finalizing the best buyer list. This is important because the ideal buyers for this congress depend heavily on what your client sells.
Example buyer mapping by product type:
- If the client sells lab equipment or scientific instruments: target lab directors, research heads, pharma R&D teams, and university labs
- If the client sells clinical trial services: target clinical development directors, CRO leaders, trial managers, and pharma project leads
- If the client sells software or data solutions: target informatics leads, biostatistics heads, clinical operations teams, and research IT buyers
- If the client sells training or consulting: target faculty, department chairs, scientific affairs leaders, and education partnerships managers
- If the client sells medical devices or diagnostics: target hospital research teams, clinical investigators, and translational medicine leaders
Once you share the client website, the buyer list can be refined much more precisely so the contact list matches the actual product, market positioning, and budget level.
9️⃣ Final recommendation
This event is a strong fit for global buyer-list generation in the pharmacology, life sciences, clinical research, and drug development ecosystem. It is especially valuable for companies targeting scientific decision-makers rather than general conference visitors.
Best buyer segments to prioritize:
- Pharmaceutical R&D leaders
- Clinical development and trial operations teams
- Biotech executives and scientists
- University faculty and research department heads
- CRO and laboratory service providers
- Medical affairs and scientific affairs leaders
- Regulatory and translational medicine teams
Quality rating for buyer-list sales: 9/10
This is a highly valuable scientific congress with strong international reach, deep industry relevance, and excellent targeting potential for life sciences and healthcare buyers. The best results will come from filtering toward senior scientific and commercial roles rather than general attendees.
Data sheet
| Event Name | 20th World Congress of Basic and Clinical Pharmacology 2026 |
| Event Date | 12 July 2026 – 17 July 2026 |
| Event Status | Upcoming |
| Venue | Melbourne Convention and Exhibition Centre |
| City | Melbourne |
| State / Region | Victoria |
| Country | Australia |
| Organizer | World Congress / pharmacology congress organizers under the IUPHAR scientific umbrella; local host participation should be reconfirmed on the official event site closer to launch. |
| Official Event Website | Organizer-linked event microsite should be rechecked before campaign launch; umbrella scientific body: iuphar.org |
| Event Type | International scientific congress / medical and life sciences conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. For planning purposes only, a world congress of this scope is likely to attract an international multi-thousand delegate audience. |
| Attendance Data Reliability | Estimated / historical congress-format assumption only; current-year public count not confirmed |
| Main Purpose of Event | To convene global basic and clinical pharmacology stakeholders around drug discovery, translational medicine, therapeutics, research collaboration, scientific education, and commercial/scientific partnership development. |
The 20th World Congress of Basic and Clinical Pharmacology 2026 is positioned as a high-value international scientific congress focused on pharmacology, therapeutics, translational research, clinical application, and drug-development science. Unlike a broad consumer expo, this is a specialist meeting where the most commercially relevant contacts typically come from pharmaceutical R&D, biotech leadership, clinical research, academic pharmacology, hospital-based research programs, regulatory science, and laboratory-focused solution buyers.
For lead generation, this event matters because it gathers decision-makers and influencers who evaluate research tools, trial support, scientific software, laboratory technologies, biomarker platforms, CRO services, translational data systems, and partnership opportunities. Its market position is strongest for companies selling into life sciences, pharma, biotech, academic medicine, and advanced research environments rather than mass-market healthcare or retail channels.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Pharmaceutical R&D leaders | Global and regional pharma companies | Evaluate preclinical models, biomarker tools, translational platforms, CRO partnerships, and scientific collaborations | High-value for research technology, outsourcing, data, and assay providers |
| Biotech founders and translational medicine teams | Biotech developers, therapeutic startups, platform innovators | Influence study design, partner selection, and platform procurement | Strong fit for enabling technologies, data platforms, and specialized service providers |
| Clinical research and trial operations teams | CROs, hospitals, academic trial centers, sponsor organizations | Assess trial support, patient data tools, monitoring, and pharmacology translation services | Relevant for eClinical, bioanalytics, recruitment, and medical affairs support vendors |
| Academic pharmacology faculty and lab heads | Universities, medical schools, institutes, pharmacology departments | Influence grants, equipment purchases, software adoption, and scientific partnerships | Important for instrument, reagents, publication, and research workflow suppliers |
| Hospital-based clinical pharmacology and therapeutics leaders | Teaching hospitals, specialist centers, clinical pharmacology units | Shape clinical adoption, protocol design, and translational research priorities | Relevant for diagnostics, data, trial support, and therapeutics infrastructure providers |
| Regulatory science and public-sector health researchers | Medicines regulators, research councils, public health agencies | Influence policy, standards, evidence generation, and program funding | Useful for policy-facing evidence, compliance, pharmacovigilance, and data quality solutions |
| Industry partnership and licensing teams | Pharma, biotech, university commercialization offices | Evaluate assets, collaborations, and scientific-commercial partnerships | Strong fit for BD, co-development, and platform partnership outreach |
| Scientific software and data-evaluation stakeholders | Research institutes, pharma analytics groups, translational teams | Assess informatics, AI, modeling, and data integration solutions | Good fit for computational biology, cloud data, and lab informatics vendors |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Melbourne | Local universities, hospitals, institutes, biotech companies | High | Melbourne is one of Australia’s strongest biomedical and research hubs. |
| Victoria | State-wide life science ecosystem participants | High | Likely strong participation from research, hospital, and biotech clusters. |
| Australia | National academic, clinical, pharmaceutical, and regulatory delegates | High | National reach is likely due to the scale and specialist nature of the congress. |
| New Zealand | Academic and medical research delegates | Medium | Natural trans-Tasman attendance corridor for pharmacology and life-science meetings. |
| Asia-Pacific | Regional pharma, biotech, universities, and translational medicine programs | High | Likely important source of international delegates due to geographic accessibility and scientific relevance. |
| Europe and North America | Senior scientific speakers, pharma leaders, global society participants | Medium to High | World congress format typically drives intercontinental participation. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event is a world congress-level scientific meeting and is expected to draw an international pharmacology audience across academia, pharma, biotech, hospitals, and scientific societies. |
| National / Asia-Pacific | Secondary concentration | Australia and the wider Asia-Pacific region are likely to represent strong concentrations of accessible delegates and target accounts. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| CSL | Pharmaceutical / biotechnology company | Australia-based global life-science buyer relevant for therapeutics, translational research, and scientific partnerships | csl.com | VP R&D, Translational Medicine Director, Clinical Pharmacology Lead, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Global pharmaceutical company | Active buyer of research, trial, and translational science capabilities | pfizer.com | Clinical Pharmacology Director, External Innovation Lead, R&D Procurement | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Global pharmaceutical company | Relevant for pharmacology, biomarker science, and clinical translation buying cycles | novartis.com | Head of Translational Medicine, Pharmacology Director, Strategic Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharmaceutical / diagnostics company | Strong fit for translational science, biomarker development, and precision medicine collaboration | roche.com | Scientific Affairs Director, Clinical Development Lead, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Global biopharmaceutical company | Relevant for clinical pharmacology, translational science, and partnership sourcing | astrazeneca.com | Director Clinical Pharmacology, Alliance Manager, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| GSK | Global pharmaceutical company | Active scientific buyer profile in therapeutics, pharmacology, and trial support ecosystems | gsk.com | Therapeutic Area Head, Clinical Research Director, R&D Sourcing | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Global pharmaceutical company | Likely buyer of drug-discovery support, translational data, and trial-enabling services | sanofi.com | Global Clinical Lead, Research Partnerships, Procurement Director | Strong Market Fit, Attendance Not Confirmed |
| IQVIA | CRO / clinical data and analytics organization | Relevant buyer of research partnerships, data integrations, and scientific services | iqvia.com | Clinical Operations Director, Data Solutions Lead, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| ICON plc | CRO | Relevant for clinical development, pharmacology trials, and sponsor-side collaboration | iconplc.com | VP Clinical Operations, Biometrics Director, Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Parexel | CRO / consulting organization | Buyer profile for trial support, data, and regulatory-science partnerships | parexel.com | Clinical Development Director, Regulatory Affairs Lead, Strategic Alliances | Strong Market Fit, Attendance Not Confirmed |
| The University of Melbourne | University / medical research institution | High-fit academic pharmacology buyer and local host-market target | unimelb.edu.au | Professor of Pharmacology, Lab Director, Research Operations Manager | Strong Market Fit, Attendance Not Confirmed |
| Monash University | University / biomedical research institution | Relevant for translational medicine, drug discovery, and pharmacology collaboration | monash.edu | Institute Director, Pharmacology Chair, Research Procurement | Strong Market Fit, Attendance Not Confirmed |
| Peter MacCallum Cancer Centre | Clinical research hospital | Relevant for translational therapeutics, oncology pharmacology, and trial support buying | petermac.org | Clinical Research Director, Therapeutics Lead, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Royal Melbourne Hospital | Teaching hospital / clinical research center | Potential buyer for clinical pharmacology, therapeutics, and research operations solutions | thermh.org.au | Director of Research, Clinical Trials Manager, Department Head | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Clinical Pharmacology | R&D / Clinical Development | Director / VP | Directly aligned to congress themes and high influence over study tools, service partners, and scientific evaluation. |
| 2 | Translational Medicine Director | Translational Research | Director | Key buyer for biomarker platforms, scientific collaborations, and translational data solutions. |
| 3 | VP R&D | Research & Development | VP | Strategic decision-maker for scientific investments and external partnerships. |
| 4 | Clinical Research Director | Clinical Operations | Director | Important for trials, protocol support, recruitment, analytics, and outsourced services. |
| 5 | Principal Investigator / Professor of Pharmacology | Academic Research | Senior Individual Contributor / Department Lead | High influence over platform selection, grants, collaborations, and pilot programs. |
| 6 | Laboratory Director | Research Operations | Director / Head | Likely buyer for instrumentation, workflow software, sample management, and services. |
| 7 | Strategic Sourcing Manager | Procurement | Manager | Useful for converting scientific interest into procurement process and supplier onboarding. |
| 8 | Business Development Director | Partnerships / Licensing | Director | Relevant for collaboration, co-development, and research alliance outreach. |
| 9 | Medical Affairs Director | Medical Affairs | Director | Influences scientific dissemination, evidence strategy, and external education initiatives. |
| 10 | Research Operations Manager | Research Administration | Manager | Practical contact for implementation, budget alignment, and vendor coordination. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core congress audience for therapeutics, pharmacology, and clinical translation | Drug discovery, clinical pharmacology, scientific sourcing |
| 2 | Biotechnology | Strong fit for translational medicine and innovation-stage therapeutic programs | Platform evaluation, collaboration, early-stage development support |
| 3 | Research | Covers institutes and scientific organizations participating in advanced pharmacology research | Academic and institute lab targeting |
| 4 | Higher Education | Universities and medical schools are major attendee segments | Faculty, department heads, research centers |
| 5 | Hospital & Health Care | Relevant for teaching hospitals, clinical pharmacology units, and translational programs | Clinical trials, therapeutics, translational workflows |
| 6 | Medical Devices | Relevant for enabling technologies used in clinical and translational settings | Diagnostics, monitoring, specialist instrumentation |
| 7 | Information Technology & Services | Many scientific buyers now evaluate data, AI, and workflow platforms | Research informatics, cloud platforms, analytics |
| 8 | Computer Software | Useful for lab software, modeling, and scientific workflow vendors | Scientific SaaS, LIMS, data management |
| 9 | Government Administration | Relevant where regulators, health agencies, or research funders participate | Regulatory science, public health, grant-funded programs |
| 10 | Medical Practice | Relevant for clinician-led therapeutic and pharmacology participation | Clinical adoption, evidence generation, protocol decisions |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer | Confirmed as unavailable | Current public data not located in organizer-facing material reviewed for this snapshot | Do not use a hard count in sales claims without organizer confirmation. |
| Planning estimate | Several thousand delegates | Estimated | World congress format, 6-day duration, international scientific scope, major convention venue | Use only for internal planning, not as a confirmed organizer figure. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor prospectus or count confirmed in this snapshot | Likely secondary to the scientific program rather than the main event feature. |
| Buyer count | Not publicly confirmed | Unconfirmed | Scientific congresses rarely publish buyer-only counts | Highest-value “buyers” are typically scientific and operational decision-makers rather than retail buyers. |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda-scale details should be checked on the official program page | Speaker organizations can become strong ABM targets once published. |
| Sponsor count | Not publicly confirmed | Unconfirmed | No verified sponsor directory confirmed in this snapshot | Sponsorship signals can later help identify budget-active organizations. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Drug discovery | Better target validation, screening, and translational relevance | Scientific demos, pilot studies, technical workshops | Assays, screening tools, discovery software, specialist CRO services |
| Clinical pharmacology | Dose-response understanding, PK/PD, translational endpoints | Clinical development meetings, targeted account outreach | Bioanalysis, modeling, data platforms, protocol support |
| Translational medicine | Bench-to-bedside linkage and biomarker strategy | Partnership discussions with translational and disease-area teams | Biomarker platforms, biosample workflows, analytics tools |
| Clinical research | Trial efficiency, site performance, evidence generation | Targeted outreach to clinical ops and trial center leaders | CRO support, eClinical software, patient data solutions |
| Laboratory technologies | Workflow efficiency, reproducibility, data integrity | Instrument-led demos and follow-up meetings | Lab equipment, LIMS, automation, sample management |
| Scientific data and AI | Interpretation, integration, modeling, decision support | Educational content and ABM outreach to informatics buyers | AI analytics, cloud data platforms, research software |
| Scientific partnerships | External innovation and co-development opportunities | BD meetings, licensing conversations, academic-industry networking | Partnership programs, co-research frameworks, alliance support |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Excellent fit for life-science, pharma, biotech, CRO, academic, and translational research solutions. |
| Decision-maker availability | Medium to High | Senior scientists and research leaders are likely present, though not all attendees will be direct budget owners. |
| Data collection potential | Medium | Useful for ABM and conference networking, but public attendee data may be limited compared with commercial expos. |
| Apollo targeting potential | High | Strong industry, title, geography, and department filters are available for pharmacology-related buyers. |
| Geographic targeting potential | High | Can be targeted by Australia, APAC, and global pharma/biotech research clusters. |
| Best outreach approach | High-value educational outreach | Best results are likely from scientific credibility, use-case framing, and account-based follow-up rather than generic event blasts. |
| Overall lead quality | High | Particularly strong for specialized B2B scientific solution providers and strategic partnership sellers. |
| Best use case | Account-based prospecting and speaker/organization mining | Ideal for building target-account lists around pharmacology, translational medicine, and clinical research buyers. |
| Limitations / risks | Medium | Public attendee transparency may be limited; scientific interest does not always equal immediate procurement intent. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Research; Higher Education; Hospital & Health Care; Medical Devices; Information Technology & Services; Computer Software; Government Administration; Medical Practice | Capture core scientific and translational buying audiences. |
| Departments | Research; Clinical; Medical Affairs; Operations; Procurement; Business Development; Information Technology | Align outreach with both scientific champions and procurement/implementation stakeholders. |
| Seniority | Director; VP; C-Level; Head; Professor; Partner; Manager | Focus on decision-makers and technical influencers. |
| Job titles | Head of Clinical Pharmacology; Translational Medicine Director; VP R&D; Clinical Research Director; Professor of Pharmacology; Laboratory Director; Medical Affairs Director; Strategic Sourcing Manager; Business Development Director; Research Operations Manager | Pinpoint the highest-fit roles for congress-related outreach. |
| Geography | Australia; New Zealand; Singapore; Japan; South Korea; China; India; United Kingdom; Germany; Switzerland; United States; Canada | Match expected international scientific attendance corridors. |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Covers growth biotech through global pharma and major research institutions. |
| Keywords | pharmacology; clinical pharmacology; translational medicine; drug discovery; therapeutics; PK/PD; biomarker; preclinical; clinical research; pharmacovigilance; assay development; bioanalytics | Improve relevance in titles, bios, and company descriptions. |
| Technologies | Use only if relevant to client offering: LIMS, cloud analytics, AI/ML research tools, eClinical systems, data integration platforms | Useful for scientific software and data-platform vendors. |
| Revenue range | Mid-market to enterprise for pharma/CRO; optional exclusion of micro firms if deal size requires | Prioritize organizations with budget and structured procurement. |
| Company type | Public companies; private companies; universities; hospitals; nonprofit research institutes | Broadens the buyer universe beyond pure commercial pharma. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Melbourne Convention and Exhibition Centre | Official venue website | Venue identity and host-city validation | High |
| IUPHAR | Official international scientific body website | Umbrella pharmacology congress context and global scientific positioning | High |
| ASCEPT | Official professional society website | Regional pharmacology and clinical-experimental pharmacology ecosystem relevance in Australasia | High |
| User-supplied event brief | Provided input | Event title, dates, and venue details used as the starting point for this data sheet | Medium |
| Verification note | Research constraint | No public current-year attendee, exhibitor, sponsor, speaker, or buyer directory was confirmed in the research snapshot reflected here. | High transparency note |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 20th World Congress of Basic and Clinical Pharmacology 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.